TSS
GH icon

Two Sigma Securities’s Guardant Health GH Stock Holding History

Two Sigma Securities’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,500
Closed -$697K – 3226
2023
Q3 		$697K Buy
23,500
+14,900
+173% +$524K 0.01% 1280
2023
Q2 		$308K Sell
8,600
-900
-9% -$25.8K ﹤0.01% 1849
2023
Q1 		$223K Buy
+9,500
New +$271K ﹤0.01% 1987
2022
Q3 		– Sell
-11,300
Closed -$456K – 2773
2022
Q2 		$456K Buy
+11,300
New +$560K 0.02% 980
2021
Q4 		– Sell
-2,400
Closed -$300K – 1728
2021
Q3 		$300K Buy
2,400
+600
+33% +$71.3K 0.01% 1002
2021
Q2 		$224K Buy
+1,800
New +$242K 0.01% 1208
2020
Q4 		– Sell
-2,400
Closed -$268K – 1766
2020
Q3 		$268K Buy
+2,400
New +$220K 0.01% 931
2020
Q1 		– Sell
-12,100
Closed -$945K – 1702
2019
Q4 		$945K Buy
12,100
+2,800
+30% +$202K 0.01% 1074
2019
Q3 		$594K Buy
+9,300
New +$819K 0.01% 1106

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Two Sigma Securities's GH Position: Q4 2024 in Review

Two Sigma Securities sold out of Guardant Health (GH) in Q4 2024, closing a stake of 22,269 shares — an estimated $511K sold.

Two Sigma Securities first reported a position in GH in Q1 2021 and held it in 8 quarters. The position peaked at $701K in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Two Sigma Securities reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 22,269 Guardant Health shares in Q4 2024, an estimated $511K.
  • Two Sigma Securities first reported a position in Guardant Health in Q1 2021 and held it in 8 quarters.
  • Two Sigma Securities's Guardant Health position peaked at $701K in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.